These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 26396236

  • 21. PANDER transgenic mice display fasting hyperglycemia and hepatic insulin resistance.
    Robert-Cooperman CE, Dougan GC, Moak SL, Athanason MG, Kuehl MN, Bell-Temin H, Stevens SM, Burkhardt BR.
    J Endocrinol; 2014 Mar; 220(3):219-31. PubMed ID: 24468680
    [Abstract] [Full Text] [Related]

  • 22. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion.
    Prada PO, Zecchin HG, Gasparetti AL, Torsoni MA, Ueno M, Hirata AE, Corezola do Amaral ME, Höer NF, Boschero AC, Saad MJ.
    Endocrinology; 2005 Mar; 146(3):1576-87. PubMed ID: 15591151
    [Abstract] [Full Text] [Related]

  • 23. Identification of a novel class of dithiolethiones that prevent hepatic insulin resistance via the adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway.
    Bae EJ, Yang YM, Kim JW, Kim SG.
    Hepatology; 2007 Sep; 46(3):730-9. PubMed ID: 17668885
    [Abstract] [Full Text] [Related]

  • 24. Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation.
    Busson M, Carazo A, Seyer P, Grandemange S, Casas F, Pessemesse L, Rouault JP, Wrutniak-Cabello C, Cabello G.
    Oncogene; 2005 Mar 03; 24(10):1698-710. PubMed ID: 15674337
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. PRDX1 is involved in palmitate induced insulin resistance via regulating the activity of p38MAPK in HepG2 cells.
    Tang Z, Xia N, Yuan X, Zhu X, Xu G, Cui S, Zhang T, Zhang W, Zhao Y, Wang S, Shi B.
    Biochem Biophys Res Commun; 2015 Oct 02; 465(4):670-7. PubMed ID: 26301632
    [Abstract] [Full Text] [Related]

  • 27. Pharmacological characterization of a small molecule inhibitor of c-Jun kinase.
    Cho H, Black SC, Looper D, Shi M, Kelly-Sullivan D, Timofeevski S, Siegel K, Yu XH, McDonnell SR, Chen P, Yie J, Ogilvie KM, Fraser J, Briscoe CP.
    Am J Physiol Endocrinol Metab; 2008 Nov 02; 295(5):E1142-51. PubMed ID: 18728225
    [Abstract] [Full Text] [Related]

  • 28. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance.
    Wei Y, Pagliassotti MJ.
    Am J Physiol Endocrinol Metab; 2004 Nov 02; 287(5):E926-33. PubMed ID: 15198936
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. B‑cell translocation 1 gene inhibits cellular metastasis‑associated behavior in breast cancer.
    Li W, Zou ST, Zhu R, Wan JM, Xu Y, Wu HR.
    Mol Med Rep; 2014 Jun 02; 9(6):2374-80. PubMed ID: 24714932
    [Abstract] [Full Text] [Related]

  • 31. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K, Hajduch E, Blair AS, Hyde R, Hundal HS.
    Biochem J; 2000 Sep 01; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [Abstract] [Full Text] [Related]

  • 32. Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver.
    Kim GH, Park EC, Yun SH, Hong Y, Lee DG, Shin EY, Jung J, Kim YH, Lee KB, Jang IS, Lee ZW, Chung YH, Choi JS, Cheong C, Kim S, Kim SI.
    Proteomics; 2013 Apr 01; 13(7):1164-79. PubMed ID: 23349036
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Nintedanib modulates surfactant protein-D expression in A549 human lung epithelial cells via the c-Jun N-terminal kinase-activator protein-1 pathway.
    Kamio K, Usuki J, Azuma A, Matsuda K, Ishii T, Inomata M, Hayashi H, Kokuho N, Fujita K, Saito Y, Miya T, Gemma A.
    Pulm Pharmacol Ther; 2015 Jun 01; 32():29-36. PubMed ID: 25843005
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Deletion of Nck1 attenuates hepatic ER stress signaling and improves glucose tolerance and insulin signaling in liver of obese mice.
    Latreille M, Laberge MK, Bourret G, Yamani L, Larose L.
    Am J Physiol Endocrinol Metab; 2011 Mar 01; 300(3):E423-34. PubMed ID: 20587749
    [Abstract] [Full Text] [Related]

  • 39. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
    Kanda M, Sugimoto H, Nomoto S, Oya H, Hibino S, Shimizu D, Takami H, Hashimoto R, Okamura Y, Yamada S, Fujii T, Nakayama G, Koike M, Fujiwara M, Kodera Y.
    Int J Oncol; 2015 Feb 01; 46(2):641-8. PubMed ID: 25405901
    [Abstract] [Full Text] [Related]

  • 40. Solidago chilensis Meyen hydroalcoholic extract reduces JNK/IκB pathway activation and ameliorates insulin resistance in diet-induced obesity mice.
    Melo AM, Bittencourt P, Nakutis FS, Silva AP, Cursino J, Santos GA, Ashino NG, Velloso LA, Torsoni AS, Torsoni MA.
    Exp Biol Med (Maywood); 2011 Oct 01; 236(10):1147-55. PubMed ID: 21844120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.